Bernard Ravina, Chief Medical Officer at Voyager Therapeutics, Inc. (VYGR), sold 16,470 shares at $14.30 ($212K) on 2017-09-11, disclosed to the SEC on 2017-09-13.
Open-market sale of $212k VYGR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.00 | 5,490 | $55K | 25.9% |
| 2 | $14.30 | 10,980 | $157K | 74.1% |
| Total | $12.87 avg | 16,470 | $212K | 100% |
| Filing → |
| VYGR | SELL | 2018-02-13 | $45K | — | Filing → |
| VYGR | SELL | 2018-01-12 | $119K | — | Filing → |
| VYGR | SELL | 2017-12-13 | $150K | — | Filing → |